Slingshot members are tracking this corporate initiative:
Novartis (NVS) Out-Licenses Two mTORC1 Inhibitors to PureTech (PTCHF)
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Mar 24, 2017 Relevance Tracked Until: Q2, 2018
Don’t see a project related to the strategic initiative you care about?
Related Keywords Out-licensing, Mtorc1 Inhibitors